GCP
PROK icon

GSA Capital Partners’s ProKidney PROK Stock Holding History

GSA Capital Partners’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$364K Buy
203,226
+14,182
+8% +$30.1K 0.02% 1125
2025
Q4 		$423K Buy
189,044
+21,013
+13% +$55.3K 0.04% 931
2025
Q3 		$407K Sell
168,031
-342,584
-67% -$912K 0.03% 990
2025
Q2 		$302K Buy
+510,615
New +$398K 0.02% 1248

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GSA Capital Partners's PROK Position: Q1 2026 in Review

GSA Capital Partners increased its ProKidney (PROK) stake by 7.5% in Q1 2026, buying an estimated $30.1K and bringing the position to 203,226 shares worth $364K. The position accounts for 0.02% of the portfolio, ranked #1125.

GSA Capital Partners first reported a position in PROK in Q2 2025 and has held it in 4 quarters since. The position peaked at $423K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • GSA Capital Partners held 203,226 shares of ProKidney worth $364K as of Q1 2026.
  • GSA Capital Partners bought 14,182 ProKidney shares in Q1 2026, an estimated $30.1K.
  • ProKidney made up 0.02% of GSA Capital Partners's portfolio in Q1 2026, its #1125 holding.
  • GSA Capital Partners first reported a position in ProKidney in Q2 2025 and has held it in 4 quarters since.
  • GSA Capital Partners's ProKidney position peaked at $423K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.